Experience

In Transition -- Actively Pursuing New Opportunities

• Advertising Services
• 1 - 100 Employee

• Market Development and Sales - Medical Devices & Life Sciences

  • Jan 2023 - Present

  Currently pursuing an opportunity to bring exciting new medical device technologies to market. Currently pursuing an opportunity to bring exciting new medical device technologies to market.



Absolute Diagnostics

• United States
• Medical Practices
• 1 - 100 Employee

• Director, Market Development

  • Apr 2022 - Dec 2022

  Developed and implemented strategies to grow lines of business in infection, toxicology, and hematology technologies. Identified an opportunity to increase revenue by targeting the Direct-to-Consumer market and recruited vital personnel with existing relationships to expand lab services to assisted living centers and home healthcare organizations. Developed and implemented strategies to grow lines of business in infection, toxicology, and hematology technologies. Identified an opportunity to increase revenue by targeting the Direct-to-Consumer market and recruited vital personnel with existing relationships to expand lab services to assisted living centers and home healthcare organizations.



Nuvaira, Inc.

• United States
• Medical Device
• 1 - 100 Employee

• Director, Therapy Adoption

  • Dec 2019 - Jul 2021

  Created and implemented patient referral development programs to reach the enrollment goals for the AIRFLOW-3 study. Led a team of three clinical specialists based in the US and partnered with the Clinical Affairs team. Helped develop, implement, and monitor a physician training program and served as the primary point of contact for customer feedback, building trust with crucial product users and relaying physician feedback. Exceeded the 2020 patient enrollment goals. Created and implemented patient referral development programs to reach the enrollment goals for the AIRFLOW-3 study. Led a team of three clinical specialists based in the US and partnered with the Clinical Affairs team. Helped develop, implement, and monitor a physician training program and served as the primary point of contact for customer feedback, building trust with crucial product users and relaying physician feedback. Exceeded the 2020 patient enrollment goals.



Broncus Medical, Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Senior Director, Market Development, Marketing and Clinical Studies

  • Sep 2016 - Nov 2019

  Effectively directed a global team of 25 people in sales, marketing, clinical, and OUS distribution for a venture capital-funded medical device company that provided a portfolio of devices for Interventional Pulmonology/Thoracic Surgery. Established a team of three country sales managers and two European distributors to launch and commercialize a novel technology for treating patients with collateral-positive emphysema. Identified, onboarded, and managed 14 distributors worldwide and re-establishing the US sales team with critical positions, including regional sales managers, a clinical support rep, a marketing director, a marketing communications manager, and a clinical research manager. * While the company was still in the market development stage, it increased sales by more than 105%. * Selected the EAST 2 clinical study hospital participants and orchestrated patient recruitment for a 106-patient study examining biopsy yield for solitary pulmonary nodules using a new bronchoscopic navigation system. The study concluded in 2019 and was published by Q1 2020. * Created market opportunity analysis for a new line of ablation catheters to treat suspicious lung nodules; the technology received FDA 510k clearance in June 2019.



Pulmonx Corporation

• United States
• Medical Equipment Manufacturing
• 100 - 200 Employee

• Director of Market Development

  • Sep 2014 - Sep 2016

  Accountable for increasing patient enrollment in US IDE study sites for a privately held medical device company focused on developing diagnostic and therapeutic technologies. Drove patient enrollment through social media, print media, patient advocacy organizations, TV news stories, and physician referral networks. Identified, developed, and nurtured relationships with key institutions and leading physicians, experienced in training physicians on the proper use of the company's products and assisting them during the clinical study, and collaborated with other internal stakeholders to support regulatory, clinical, and development activities. * Developed a proposal to focus on directly informing patients about the LIBERATE study through various media outlets and patient advocacy groups led to a significant increase in patient enrollment, allowing the company to complete the study ahead of schedule and receive FDA approval for the treatment. Enrollment drastically increased from 20 to 200 patients, a 1000% increase in under 18 months. In June 2018, the Zephyr EBV received FDA approval based on study results. This led to the company performing an IPO on the NASDAQ market in 2020.



Broncus Medical, Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director, Global Sales, Market Development & Marketing

  • Mar 2012 - Sep 2014

  Established a team of regional sales and marketing managers to achieve commercialization objectives in the US market for a venture capital-funded medical device company that provided a portfolio of devices related to Interventional Pulmonology/Thoracic Surgery. Orchestrated product launches in international markets recognizing the CE mark by conducting market analysis, developing revenue models, and identifying and establishing key opinion leaders (KOLs) as champions. Identified, trained, and managed international distributors in Europe, Asia, and South America while providing physician proctoring and case coverage in those overseas markets. * Created a proposal to develop a system that would allow pulmonologists to access suspicious pulmonary nodules located outside of the airways without performing invasive procedures. This led to the development of a new system that achieved clinical trial success, received regulatory approval in multiple countries, and fulfilled the needs of clinicians and patients for a minimally invasive procedure. This resulted in significant commercial success, selling more than 100 systems globally at an average selling price of $100,000, allowing the company to perform an IPO on the Hong Kong Exchange in 2021.

• Southeast Region Sales Manager

  • May 2009 - Mar 2012

  Developed the market for new medical technologies that provided 3D virtual bronchoscopic procedure planning and navigation and a diagnostic biopsy catheter for lung diseases. Assisted the Global VP of Sales in building a direct sales team for the US launch of three products in 2010. Identified a market opportunity to separate and expand the procedure planning software in the radiology market.* Separated two software modules of a bronchoscopic navigation system and offered the procedure planning software as a standalone, less expensive alternative to increase sales and expand the technology's market share. Sold more than 100 systems at an average selling price of $15,000, generating $1.5M in revenue and a profit margin of approximately 500% per system. This system was a driving revue force and was commercialized in the US, Canada, Europe, and Asian markets.* Consistently finished #1 in US sales amongst four Regions from 2009 through 2012.



Alveolus Inc.

• Charlotte, North Carolina Area

• Co Principal, Key Account Manager

  • Feb 2008 - Apr 2009

  Educated, trained and sold to Thoracic Surgeons, Interventional Pulmonologists, Gastroenterologists, Bariatric Surgeons, and Surgical Oncologists who used non-vascular stents for obstructive disease and leaks in the tracheobronchial, esophageal, and biliary anatomy. Identified and implemented new device designs for stents and delivery systems with engineers and critical opinion-leading physicians. Originated business development and marketing programs, including physician education outreach programs, product training and demonstration tools, and patient education literature. * Regained business at 11 dormant accounts, established eight new accounts and increased business at 11 current accounts.



Guidant/Abbott Vascular

• Santa Clara, CA

• Senior Territory Manager

  • Apr 2004 - Sep 2007

  Sold carotid stents, embolic protection devices, peripheral balloon dilators, guidewires, and biliary stents. Crafted economic programs that reduced costs and increased revenue for hospitals and physicians. Trained physicians to use the stent systems and assisted ten hospitals with the CMS credentialing for carotid artery stenting. * Launched a carotid artery stent system that faced challenges due to physician hesitancy. To overcome this, partnered with physicians who believed in the therapy and held educational events that increased the number of referring physicians, resulting in a 242% increase in revenue ($1M) in one year. * Increased territory revenue by more than 242% and $1M in 2005, following an increase in revenue by more than 55% and $387,653 in 2004. * Consistently exceeded sales plan: 108% 2004, 109% 2005, 105% 2006.



Boston Scientific

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Sales Trainer

  • May 2000 - Apr 2004

  • Responsible for training new territory managers on the clinical aspects and selling strategies for stents, biliary, dilation, hemostasis, polypectomy, tissue biopsy, GERD, and enteral feeding devices.

• Territory Manager

  • Oct 1997 - May 2000

  • Responsible for selling a variety of endo-prosthetic stents, diagnostic, and therapeutic endoscopic instruments to Gastroenterologists, General Surgeons, Thoracic Surgeons, ENT Surgeons, Colo-rectal Surgeons, Pulmonologists, and Radiologists.• Experienced in conducting accredited continuing education courses for physicians, nurses, and techs.